Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).
The understanding of how cerebrovascular disease (CVD) contributes to dementia is hampered by a lack of agreed and validated pathologic methods to accord weight to the contribution of different aspects of CVD to dementia. A previous study from the Oxford Project to Investigate Memory and Ageing (OPT...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2014
|
| _version_ | 1826302871335862272 |
|---|---|
| author | Esiri, M Joachim, C Sloan, C Christie, S Agacinski, G Bridges, L Wilcock, G Smith, A |
| author_facet | Esiri, M Joachim, C Sloan, C Christie, S Agacinski, G Bridges, L Wilcock, G Smith, A |
| author_sort | Esiri, M |
| collection | OXFORD |
| description | The understanding of how cerebrovascular disease (CVD) contributes to dementia is hampered by a lack of agreed and validated pathologic methods to accord weight to the contribution of different aspects of CVD to dementia. A previous study from the Oxford Project to Investigate Memory and Ageing (OPTIMA) validated a scheme for assessing the contribution of subcortical small vessel disease (SVD) toward dementia in the elderly by showing a significant inverse relationship between the severity of SVD and cognition in subjects without any other dementia pathology using this method. In the present paper, the method has been used to assess severity of SVD in 161 cases of neuropathologically confirmed Alzheimer disease. The results showed there was no relationship between the SVD score and cognitive scores acquired in the last 2 years of life. SVD scores were significantly related to age (P<0.0017) and were slightly but significantly higher in females than males (P<0.049). SVD scores were not related to blood pressure at entry to OPTIMA and were significantly lower when compared with the cohort of OPTIMA cases with only CVD (mean 5.06 ± 1.85 vs. 5.9 ± 2.67; P<0.0065). We conclude that when Alzheimer disease pathology is present in elderly subjects, it overwhelms the modest contribution that SVD makes to cognitive impairment. |
| first_indexed | 2024-03-07T05:54:01Z |
| format | Journal article |
| id | oxford-uuid:e9e40b1f-5f3f-4fb0-ace4-a6e0a4319704 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:54:01Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:e9e40b1f-5f3f-4fb0-ace4-a6e0a43197042022-03-27T10:57:35ZCerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e9e40b1f-5f3f-4fb0-ace4-a6e0a4319704EnglishSymplectic Elements at Oxford2014Esiri, MJoachim, CSloan, CChristie, SAgacinski, GBridges, LWilcock, GSmith, AThe understanding of how cerebrovascular disease (CVD) contributes to dementia is hampered by a lack of agreed and validated pathologic methods to accord weight to the contribution of different aspects of CVD to dementia. A previous study from the Oxford Project to Investigate Memory and Ageing (OPTIMA) validated a scheme for assessing the contribution of subcortical small vessel disease (SVD) toward dementia in the elderly by showing a significant inverse relationship between the severity of SVD and cognition in subjects without any other dementia pathology using this method. In the present paper, the method has been used to assess severity of SVD in 161 cases of neuropathologically confirmed Alzheimer disease. The results showed there was no relationship between the SVD score and cognitive scores acquired in the last 2 years of life. SVD scores were significantly related to age (P<0.0017) and were slightly but significantly higher in females than males (P<0.049). SVD scores were not related to blood pressure at entry to OPTIMA and were significantly lower when compared with the cohort of OPTIMA cases with only CVD (mean 5.06 ± 1.85 vs. 5.9 ± 2.67; P<0.0065). We conclude that when Alzheimer disease pathology is present in elderly subjects, it overwhelms the modest contribution that SVD makes to cognitive impairment. |
| spellingShingle | Esiri, M Joachim, C Sloan, C Christie, S Agacinski, G Bridges, L Wilcock, G Smith, A Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). |
| title | Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). |
| title_full | Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). |
| title_fullStr | Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). |
| title_full_unstemmed | Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). |
| title_short | Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). |
| title_sort | cerebral subcortical small vessel disease in subjects with pathologically confirmed alzheimer disease a clinicopathologic study in the oxford project to investigate memory and ageing optima |
| work_keys_str_mv | AT esirim cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima AT joachimc cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima AT sloanc cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima AT christies cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima AT agacinskig cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima AT bridgesl cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima AT wilcockg cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima AT smitha cerebralsubcorticalsmallvesseldiseaseinsubjectswithpathologicallyconfirmedalzheimerdiseaseaclinicopathologicstudyintheoxfordprojecttoinvestigatememoryandageingoptima |